SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-254171
Filing Date
2020-09-25
Accepted
2020-09-25 12:28:52
Documents
4
Period of Report
2020-10-29
Effectiveness Date
2020-09-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d37466ddef14a.htm DEF 14A 393692
2 GRAPHIC g37466dsp022.jpg GRAPHIC 305294
3 GRAPHIC g37466dsp023.jpg GRAPHIC 179368
4 GRAPHIC g37466g19i90.jpg GRAPHIC 67326
  Complete submission text file 0001193125-20-254171.txt   1155605
Mailing Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355
Business Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355 661-367-9170
Avita Therapeutics, Inc. (Filer) CIK: 0001762303 (see all company filings)

IRS No.: 202578762 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-39059 | Film No.: 201198238
SIC: 3841 Surgical & Medical Instruments & Apparatus